The first Jurassic World Rebirth trailer kept things pretty vague, as it had to spend time introducing characters the audience has no real connection to yet. But, even with the li ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Here are three fantastic biotech stocks harnessing the power of AI that could make a great addition to your portfolio. The ...

Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its ...

Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

Robert F. Kennedy Jr’s message of eliminating toxins and investigating public health agencies has resonated among a key group ...

MicroStrategy Inc. (NASDAQ:MSTR) has officially rebranded as Strategy, reflecting its sharpened focus on Bitcoin ...

Beta Bionics (BBNX) leads innovation in the diabetes treatment market with its groundbreaking iLet Bionic Pancreas technology ...

United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

MicroStrategy, the business intelligence firm and Bitcoin treasury company co-founded by Michael Saylor has rebranded to ...